Simple Summary In recent decades, neoadjuvant chemotherapy has proven to be a viable
therapeutic option, particularly in cases of high-risk early or locally advanced breast cancer …

The analysis of circulating tumor cells and tumor-derived materials, such as circulating tumor
DNA, circulating miRNAs (cfmiRNAs), and extracellular vehicles provides crucial information …

The increased understanding of the competitive endogenous RNA (ceRNA) network in the
onset and development of breast cancers has suggested their use as promising disease …

Objective Triple-negative breast cancer (TNBC) is a very aggressive form of cancer that
grows and spreads very fast and generally relapses. Therapeutic options of TNBC are …

Breast cancer is significantly influenced by endoplasmic reticulum (ER) stress, impacting
both its initiation and progression. When cells experience an accumulation of misfolded or …

Introduction: Circular RNAs (circRNAs) regulatory network is important in human cancer.
We, therefore, mapped the regulatory networks driven by circRNA in luminal-subtype breast …

ABSTRACT Introduction Non-coding RNAs (ncRNAs) comprise a heterogeneous cluster of
RNA molecules. Emerging evidence suggests their involvement in various aspects of …

Cancer stem cells (CSCs) have a crucial function in the initiation, advancement, and
resistance to therapy of tumors. Recent findings indicate that non-coding RNAs (ncRNAs) …

Abstract Zinc finger antisense 1 (ZFAS1), a newly discovered long noncoding RNA, is
expressed in various tissues and organs and has been introduced an oncogenic gene in …

Non-coding RNAs (ncRNAs) are a diverse group of functional RNA molecules that lack the
ability to code for proteins. Despite missing this traditional role, ncRNAs have emerged as …